Sign in

CIK 0001506251

  • Non-accelerated filer
  • Smaller reporting company

Citius Pharmaceuticals, Inc.

Sign in to watch
Ticker
CTXR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
NV
Entity type
Operating
EIN
273425913
Phone
+1 908-967-6676
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
Trail One, Inc., TrailOne, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-08-08 Mazur Leonard L Chief Executive Officer Returned to the company · Warrant to Purchase Common Stock −125,490 0
2025-08-08 Mazur Leonard L Chief Executive Officer Grant or award · Warrant to Purchase Common Stock +125,490 125,490
2025-08-08 Mazur Leonard L Chief Executive Officer Returned to the company · Warrant to Purchase Common Stock −89,388 0
2025-08-08 Mazur Leonard L Chief Executive Officer Grant or award · Warrant to Purchase Common Stock +89,388 89,388
2025-08-08 HOLUBIAK MYRON Z Vice Chairman Returned to the company · Warrant to Purchase Common Stock −31,373 0
2025-08-08 HOLUBIAK MYRON Z Vice Chairman Grant or award · Warrant to Purchase Common Stock +31,373 31,373
2025-08-08 HOLUBIAK MYRON Z Vice Chairman Returned to the company · Warrant to Purchase Common Stock −22,344 0
2025-08-08 HOLUBIAK MYRON Z Vice Chairman Grant or award · Warrant to Purchase Common Stock +22,344 22,344
2024-11-07 Webb Carol Director Grant or award · Stock Option (Right to Purchase Common Stock) +125,000 125,000
2024-11-07 Smith Robert Joseph Director Grant or award · Stock Option (Right to Purchase Common Stock) +125,000 125,000
2024-11-07 Bartushak Jaime Chief Financial Officer Grant or award · Stock Option (Right to Purchase Common Stock) +350,000 350,000
2024-11-07 Mazur Leonard L Chief Executive Officer Grant or award · Stock Option (Right to Purchase Common Stock) +600,000 600,000
2024-11-07 Czuczman Myron Chief Medical Officer Grant or award · Stock Option (Right to Purchase Common Stock) +300,000 300,000
2024-11-07 Dutia Suren G Director Grant or award · Stock Option (Right to Purchase Common Stock) +125,000 125,000
2024-11-07 MCGRATH DENNIS M Director Grant or award · Stock Option (Right to Purchase Common Stock) +125,000 125,000
2024-11-07 HOLUBIAK MYRON Z Vice Chairman Grant or award · Stock Option (Right to Purchase Common Stock) +350,000 350,000
2024-11-07 HOLUBIAK MYRON Z Vice Chairman Grant or award · Stock Option (Right to Buy) +75,000 75,000
2024-11-07 Holuka Eugene Myron Director Grant or award · Stock Option (Right to Purchase Common Stock) +125,000 125,000
2024-09-25 HOLUBIAK MYRON Z Vice Chairman Returned to the company · Warrant to Purchase Common Stock −558,597 0
2024-09-25 HOLUBIAK MYRON Z Vice Chairman Grant or award · Warrant to Purchase Common Stock +558,597 558,597

Page 1 of 8 · 156 trades